Tandem Diabetes Care (TNDM) Deferred Taxes (2019)
Tandem Diabetes Care posted quarterly Deferred Taxes of -$25000.0 for Q4 2019.
Tandem Diabetes Care (TNDM) has 1 years of Deferred Taxes data on file, last reported at -$25000.0 in Q4 2019.
- For the quarter ending Q4 2019, Deferred Taxes changed N/A year-over-year to -$25000.0; the trailing twelve-month figure through Sep 2021 stood at -$25000.0 (changed N/A YoY), and the FY2020 full-year result was -$2.1 million, down 8404.0% from the prior year.
- Deferred Taxes for Q4 2019 stood at -$25000.0.
- Across five years, Deferred Taxes topped out at -$25000.0 in Q4 2019 and bottomed at -$25000.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -101.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 300,000.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -16.70 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -25,000.00 |